1.
|
Lau WY and Lai EC: Hepatocellular
carcinoma: current management and recent advances. Hepatobiliary
Pancreat Dis Int. 7:237–257. 2008.PubMed/NCBI
|
2.
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Simeone DM: Pancreatic cancer stem cells:
implications for the treatment of pancreatic cancer. Clin Cancer
Res. 14:5646–5648. 2008. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
5.
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
9.
|
Kruger M, Schwarz A and Blumich B:
Investigations of silicone breast implants with the NMR-MOUSE. Magn
Reson Imaging. 25:215–218. 2007. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Mitsutake N, Iwao A, Nagai K, et al:
Characterization of side population in thyroid cancer cell lines:
cancer stem-like cells are enriched partly but not exclusively.
Endocrinology. 148:1797–1803. 2007. View Article : Google Scholar : PubMed/NCBI
|
11.
|
Zhang N, Li R, Tao KS, et al:
Characterization of a stem-like population in hepatocellular
carcinoma MHCC97 cells. Oncol Rep. 23:827–831. 2010.PubMed/NCBI
|
12.
|
Ambros V: MicroRNA pathways in flies and
worms: growth, death, fat, stress and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Liu C, Yu J, Yu S, et al: MicroRNA-21 acts
as an oncomir through multiple targets in human hepatocellular
carcinoma. J Hepatol. 53:98–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
14.
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
15.
|
Asangani IA, Rasheed SA, Nikolova DA, et
al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor
suppressor Pdcd4 and stimulates invasion, intravasation and
metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008.
View Article : Google Scholar
|
16.
|
Gabriely G, Wurdinger T, Kesari S, et al:
MicroRNA 21 promotes glioma invasion by targeting matrix
metalloproteinase regulators. Mol Cell Biol. 28:5369–5380. 2008.
View Article : Google Scholar : PubMed/NCBI
|
17.
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
18.
|
Devreotes P and Janetopoulos C: Eukaryotic
chemotaxis: distinctions between directional sensing and
polarization. J Biol Chem. 278:20445–20448. 2003. View Article : Google Scholar : PubMed/NCBI
|
19.
|
Tang DJ, Dong SS, Ma NF, et al:
Overexpression of eukaryotic initiation factor 5A2 enhances cell
motility and promotes tumor metastasis in hepatocellular carcinoma.
Hepatology. 51:1255–1263. 2010. View Article : Google Scholar : PubMed/NCBI
|
20.
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
21.
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Matsui W, Huff CA, Wang Q, et al:
Characterization of clonogenic multiple myeloma cells. Blood.
103:2332–2336. 2004. View Article : Google Scholar : PubMed/NCBI
|
23.
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
24.
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, et al: Ovarian cancer side population defines cells with stem
cell-like characteristics and Mullerian Inhibiting Substance
responsiveness. Proc Natl Acad Sci USA. 103:11154–11159. 2006.
View Article : Google Scholar : PubMed/NCBI
|
25.
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
26.
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
27.
|
Iorio MV, Visone R, Di Leva G, et al:
MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
28.
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
29.
|
Bloomston M, Frankel WL, Petrocca F, et
al: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
30.
|
Feber A, Xi L, Luketich JD, et al:
MicroRNA expression profiles of esophageal cancer. J Thorac
Cardiovasc Surg. 135:255–260. 2008. View Article : Google Scholar
|
31.
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
32.
|
Krichevsky AM and Gabriely G: miR-21: a
small multi-faceted RNA. J Cell Mol Med. 13:39–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
33.
|
Grunder E, D’Ambrosio R, Fiaschetti G, et
al: MicroRNA-21 suppression impedes medulloblastoma cell migration.
Eur J Cancer. 47:2479–2490. 2011. View Article : Google Scholar : PubMed/NCBI
|
34.
|
Li J, Yen C, Liaw D, et al: PTEN, a
putative protein tyrosine phosphatase gene mutated in human brain,
breast and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
35.
|
Salmena L, Carracedo A and Pandolfi PP:
Tenets of PTEN tumor suppression. Cell. 133:403–414. 2008.
View Article : Google Scholar : PubMed/NCBI
|
36.
|
Bedolla R, Prihoda TJ, Kreisberg JI, et
al: Determining risk of biochemical recurrence in prostate cancer
by immunohistochemical detection of PTEN expression and Akt
activation. Clin Cancer Res. 13:3860–3867. 2007. View Article : Google Scholar : PubMed/NCBI
|
37.
|
Yoshimoto M, Cunha IW, Coudry RA, et al:
FISH analysis of 107 prostate cancers shows that PTEN genomic
deletion is associated with poor clinical outcome. Br J Cancer.
97:678–685. 2007. View Article : Google Scholar : PubMed/NCBI
|
38.
|
Yu J, Zhang SS, Saito K, et al: PTEN
regulation by Akt-EGR1-ARF-PTEN axis. EMBO J. 28:21–33. 2009.
View Article : Google Scholar : PubMed/NCBI
|
39.
|
Noda M, Oh J, Takahashi R, Kondo S,
Kitayama H and Takahashi C: RECK: a novel suppressor of malignancy
linking oncogenic signaling to extracellular matrix remodeling.
Cancer Metastasis Rev. 22:167–175. 2003. View Article : Google Scholar : PubMed/NCBI
|
40.
|
Takahashi C, Sheng Z, Horan TP, et al:
Regulation of matrix metalloproteinase-9 and inhibition of tumor
invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad
Sci USA. 95:13221–13226. 1998. View Article : Google Scholar : PubMed/NCBI
|
41.
|
Clark JC, Thomas DM, Choong PF and Dass
CR: RECK - a newly discovered inhibitor of metastasis with
prognostic significance in multiple forms of cancer. Cancer
Metastasis Rev. 26:675–683. 2007. View Article : Google Scholar : PubMed/NCBI
|
42.
|
Noda M and Takahashi C: Recklessness as a
hallmark of aggressive cancer. Cancer Sci. 98:1659–1665. 2007.
View Article : Google Scholar : PubMed/NCBI
|
43.
|
Kotzsch M, Farthmann J, Meye A, et al:
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression
levels in breast cancer. Eur J Cancer. 41:2760–2768. 2005.
View Article : Google Scholar : PubMed/NCBI
|
44.
|
Takenaka K, Ishikawa S, Kawano Y, et al:
Expression of a novel matrix metalloproteinase regulator, RECK and
its clinical significance in resected non-small cell lung cancer.
Eur J Cancer. 40:1617–1623. 2004. View Article : Google Scholar : PubMed/NCBI
|
45.
|
Allgayer H: Pdcd4, a colon cancer
prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol.
73:185–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
46.
|
Cmarik JL, Min H, Hegamyer G, et al:
Differentially expressed protein Pdcd4 inhibits tumor
promoter-induced neoplastic transformation. Proc Natl Acad Sci USA.
96:14037–14042. 1999. View Article : Google Scholar : PubMed/NCBI
|
47.
|
Jansen AP, Camalier CE and Colburn NH:
Epidermal expression of the translation inhibitor programmed cell
death 4 suppresses tumorigenesis. Cancer Res. 65:6034–6041. 2005.
View Article : Google Scholar : PubMed/NCBI
|
48.
|
Lankat-Buttgereit B and Goke R: The tumour
suppressor Pdcd4: recent advances in the elucidation of function
and regulation. Biol Cell. 101:309–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
49.
|
Yang HS, Matthews CP, Clair T, et al:
Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated
protein kinase kinase kinase kinase 1 expression to suppress colon
carcinoma cell invasion. Mol Cell Biol. 26:1297–1306. 2006.
View Article : Google Scholar : PubMed/NCBI
|
50.
|
Wang Q, Sun Z and Yang HS: Downregulation
of tumor suppressor Pdcd4 promotes invasion and activates both
beta-catenin/Tcf and AP-1-dependent transcription in colon
carcinoma cells. Oncogene. 27:1527–1535. 2008. View Article : Google Scholar : PubMed/NCBI
|
51.
|
Nieves-Alicea R, Colburn NH, Simeone AM
and Tari AM: Programmed cell death 4 inhibits breast cancer cell
invasion by increasing tissue inhibitor of metalloproteinase-2
expression. Breast Cancer Res Treat. 114:203–209. 2009. View Article : Google Scholar : PubMed/NCBI
|
52.
|
Zhang S, Li J, Jiang Y, Xu Y and Qin C:
Programmed cell death 4 (PDCD4) suppresses metastastic potential of
human hepatocellular carcinoma cells. J Exp Clin Cancer Res.
28:712009. View Article : Google Scholar : PubMed/NCBI
|